150 related articles for article (PubMed ID: 38301810)
1. Recent progress on polySarcosine as an alternative to PEGylation: Synthesis and biomedical applications.
Kabil MF; Azzazy HME; Nasr M
Int J Pharm; 2024 Mar; 653():123871. PubMed ID: 38301810
[TBL] [Abstract][Full Text] [Related]
2. Polysarcosine as an Alternative to PEG for Therapeutic Protein Conjugation.
Hu Y; Hou Y; Wang H; Lu H
Bioconjug Chem; 2018 Jul; 29(7):2232-2238. PubMed ID: 29863329
[TBL] [Abstract][Full Text] [Related]
3. Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death.
Yao X; Sun C; Xiong F; Zhang W; Yao W; Xu Y; Fan W; Huo F
ACS Appl Mater Interfaces; 2024 Apr; 16(15):19472-19479. PubMed ID: 38572784
[TBL] [Abstract][Full Text] [Related]
4. Evasion of the accelerated blood clearance phenomenon by polysarcosine coating of liposomes.
Son K; Ueda M; Taguchi K; Maruyama T; Takeoka S; Ito Y
J Control Release; 2020 Jun; 322():209-216. PubMed ID: 32194174
[TBL] [Abstract][Full Text] [Related]
5. PEG-amine-initiated polymerization of sarcosine N-thiocarboxyanhydrides toward novel double-hydrophilic PEG-b-polysarcosine diblock copolymers.
Tao X; Deng C; Ling J
Macromol Rapid Commun; 2014 May; 35(9):875-81. PubMed ID: 24668926
[TBL] [Abstract][Full Text] [Related]
6. Utility of Triethyloxonium Tetrafluoroborate for Chloride Removal during Sarcosine N-Carboxyanhydride Synthesis: Improving NCA Purity.
Capelôa L; Miravet Martí R; Duro-Castaño A; Nebot VJ; Barz M
Chemistry; 2024 Jun; 30(31):e202304375. PubMed ID: 38563634
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable Polysarcosine with Inserted Alanine Residues: Synthesis and Enzymolysis.
Zhou P; Shen T; Chen W; Sun J; Ling J
Biomacromolecules; 2022 Apr; 23(4):1757-1764. PubMed ID: 35293717
[TBL] [Abstract][Full Text] [Related]
8. Surface-grafted polysarcosine as a peptoid antifouling polymer brush.
Lau KH; Ren C; Sileika TS; Park SH; Szleifer I; Messersmith PB
Langmuir; 2012 Nov; 28(46):16099-107. PubMed ID: 23101930
[TBL] [Abstract][Full Text] [Related]
9. Oxidation-Sensitive Polymersomes Based on Amphiphilic Diblock Copolypeptoids.
Deng Y; Chen H; Tao X; Cao F; Trépout S; Ling J; Li MH
Biomacromolecules; 2019 Sep; 20(9):3435-3444. PubMed ID: 31361468
[TBL] [Abstract][Full Text] [Related]
10. Polysarcosine brush stabilized gold nanorods for in vivo near-infrared photothermal tumor therapy.
Zhu H; Chen Y; Yan FJ; Chen J; Tao XF; Ling J; Yang B; He QJ; Mao ZW
Acta Biomater; 2017 Mar; 50():534-545. PubMed ID: 28027959
[TBL] [Abstract][Full Text] [Related]
11. Poly(Sarcosine) Surface Modification Imparts Stealth-Like Properties to Liposomes.
Bleher S; Buck J; Muhl C; Sieber S; Barnert S; Witzigmann D; Huwyler J; Barz M; Süss R
Small; 2019 Dec; 15(50):e1904716. PubMed ID: 31722126
[TBL] [Abstract][Full Text] [Related]
12. Polysarcosine-based lipid formulations for intracranial delivery of mRNA.
Bi D; Unthan DM; Hu L; Bussmann J; Remaut K; Barz M; Zhang H
J Control Release; 2023 Apr; 356():1-13. PubMed ID: 36803765
[TBL] [Abstract][Full Text] [Related]
13. Lysine-Sarcosine PiPo Functionalized Surface with Excellent Hemocompatibility.
Hao K; Cui R; Fang L; Ling J; Zhu B
ACS Appl Mater Interfaces; 2023 Jun; 15(25):29700-29712. PubMed ID: 37306970
[TBL] [Abstract][Full Text] [Related]
14. Improving aqueous solubility of paclitaxel with polysarcosine-b-poly(γ-benzyl glutamate) nanoparticles.
Lebleu C; Plet L; Moussy F; Gitton G; Da Costa Moreira R; Guduff L; Burlot B; Godiveau R; Merry A; Lecommandoux S; Errasti G; Philippe C; Delacroix T; Chakrabarti R
Int J Pharm; 2023 Jan; 631():122501. PubMed ID: 36529355
[TBL] [Abstract][Full Text] [Related]
15. Polypeptides as alternatives to PEGylation of therapeutic agents.
Chen H; Zhang Q
Expert Opin Drug Deliv; 2024; 21(1):1-12. PubMed ID: 38116624
[TBL] [Abstract][Full Text] [Related]
16. Tubular Network Formation by Mixing Amphiphilic Polypeptides with Differing Hydrophilic Blocks.
Rahman MM; Ueda M; Son K; Seo S; Takeoka S; Hirose T; Ito Y
Biomacromolecules; 2019 Oct; 20(10):3908-3914. PubMed ID: 31532187
[TBL] [Abstract][Full Text] [Related]
17. On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s.
Ulbricht J; Jordan R; Luxenhofer R
Biomaterials; 2014 Jun; 35(17):4848-61. PubMed ID: 24651032
[TBL] [Abstract][Full Text] [Related]
18. Beyond PEGylation: Alternative surface-modification of nanoparticles with mucus-inert biomaterials.
Khutoryanskiy VV
Adv Drug Deliv Rev; 2018 Jan; 124():140-149. PubMed ID: 28736302
[TBL] [Abstract][Full Text] [Related]
19. Polysarcosine-Coated liposomes attenuating immune response induction and prolonging blood circulation.
Hu M; Taguchi K; Matsumoto K; Kobatake E; Ito Y; Ueda M
J Colloid Interface Sci; 2023 Dec; 651():273-283. PubMed ID: 37542902
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticles coated with polysarcosine brushes to enhance their colloidal stability and circulation time in vivo.
Chen Y; Xu Z; Zhu D; Tao X; Gao Y; Zhu H; Mao Z; Ling J
J Colloid Interface Sci; 2016 Dec; 483():201-210. PubMed ID: 27552428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
